← Leaderboards
Edward Hook
University Of Alabama At Birmingham
$17,521,535
Attributed
$17,521,535
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.6M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,521,535 · 1
By mechanism
N01$17,521,535 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Jane R. Schwebke$12,395,911
- Renee A. Heffron$19,065,543
- Holly E Richter$12,519,508
- Edward W Hook$14,329,104
- Eric Hunter$78,178,241
Others in their field
Top investigators on “Sample Collection”
- Jeffrey P Krischer · University Of South Florida$456,066,946
- David R. Weir · University Of Michigan At Ann Arbor$419,503,632
- Marian Ewell · The Emmes Company, Llc$278,931,253
- David Heimbrook · Leidos Biomedical Research, Inc.$257,130,043
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$168,397,299
- Ralph Parchment · Leidos Biomedical Research, Inc.$166,581,916
Research focus
Sample CollectionSexually Transmitted DiseasesClinical Research SiteTrainingClinical TrialsClinical Trials Cooperative GroupBiologicalLeadershipClinical ResearchProtocol DevelopmentHuman ResourcesLaboratoriesResearch InfrastructureProceduresDiagnosticInfrastructureSex BehaviorCommunicable DiseasesLaboratory PersonnelTherapeutic DevelopmentNeisseria GonorrhoeaeTreatment GroupBacterial Drug ResistanceMycoplasma Genitalium
Grant awards (23)
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae$1,046,990
N01 · FY2025 · AI · contact PI
Task 12: Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae$848,444
N01 · FY2024 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Phase III Clinical Trial for Syphilis Therapeutics$1,339,905
N01 · FY2020 · AI · contact PI
Sexually Transmitted Infections Clinical Trial Group: Treatment of Gardnerella Vaginalis$876,978
N01 · FY2019 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Treatment of Mycoplasma Genitalium$288,930
N01 · FY2019 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$93,781
N01 · FY2019 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$93,781
N01 · FY2019 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Phase II Clinical Trial for Bacterial Vaginosis$2,277,679
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Development and Validation of Diagnostic Tools for Drug Resistant STIs$2,079,705
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Phase III Clinical Trial for Syphilis Therapeutics$1,384,298
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$333,660
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$333,660
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trial Group: Treatment of Gardnerella Vaginalis$89,025
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Treatment of Mycoplasma Genitalium$84,719
N01 · FY2018 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Phase IV Chlamydia Clinical Trial$976,630
N01 · FY2017 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$594,954
N01 · FY2017 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Phase III Clinical Trial for Syphilis Therapeutics$538,961
N01 · FY2017 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$436,930
N01 · FY2017 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group: Treatment of Mycoplasma Genitalium$1,296,598
N01 · FY2016 · AI · contact PI
Sexually Transmitted Infections Clinical Trial Group: Treatment of Gardnerella Vaginalis$934,829
N01 · FY2016 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$654,490
N01 · FY2016 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$263,738
N01 · FY2016 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$652,850
N01 · FY2015 · AI · contact PI